Reduction by paroxetine of suicidal behavior in patients with repeated suicide attempts but not major depression

American Journal of Psychiatry

Volumn 155, Issue 4, 1998, Pages 543-547

  Verkes, Robbert J ^a   Van der Mast, Rose C ^b   Hengeveld, Michiel W ^b   Tuyl, Jolien P ^b   Zwinderman, Aeilko H ^b   Van Kempen, Godfried M J ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANGER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DOUBLE BLIND PROCEDURE; ECCHYMOSIS; FEMALE; HUMAN; MALE; MENTAL DISEASE; PERSONALITY DISORDER; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RECURRENT DISEASE; SEROTONINERGIC SYSTEM; SEXUAL DYSFUNCTION; SUICIDE ATTEMPT; TREATMENT OUTCOME; TREMOR;

EID: 0031956206     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.155.4.543     Document Type: Article

References (35)

1. Roy A, Linnoila M: Monoamines and suicidal behavior, in Violence and Suicidality. Edited by Van Praag HM, Plutchik R, Apter A. New York, Brunner/Mazel, 1990, pp 141-183
2. Van Praag HM: Serotonergic dysfunction and aggression control. Psychol Med 1991; 21:15-19
3. Åsberg M, Schalling D, Träskman-Bendz L, Wägner A: Psychobiology of suicide, impulsivity, and related phenomena, in Psychopharmacology: The Third Generation of Progress. Edited by Meltzer HY. New York, Raven Press, 1987, pp 655-668
4. Mann JJ, Kapur S: The emergence of suicidal ideation and behavior during antidepressant pharmacotherapy. Arch Gen Psychiatry 1991; 48:1027-1033
5. Filteau MJ, Lapierre YD, Bakish D, Blanchard A: Reduction in suicidal ideation with SSRIs: a review of 459 depressed patients. J Neurol Neurosurg Psychiatry 1993; 18:114-119
6. Teicher MH, Glod C, Cole JO: Emergence of intense suicidal preoccupation during fluoxetine treatment. Am J Psychiatry 1990; 147:207-210
7. Wirshing WC, Van Putten T, Rosenberg J, Marder S, Ames D, Hicks-Gray T: Fluoxetine, akathisia, and suicidality: is there a causal connection? (letter). Arch Gen Psychiatry 1992; 49:580-581
8. King RA, Riddle MA, Chappell PB, Hardin MT, Anderson GM, Lombroso P, Scahill L: Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiatry 1991; 30:179-186
9. Rothschild AJ, Locke CA: Reexposure to fluoxetine after serious suicide attempts by three patients: the role of akathisia. J Clin Psychiatry 1991; 52:491-493
10. Lebegue B: Sudden self-harm while taking fluoxetine (letter). Am J Psychiatry 1992; 149:1113
11. Beasley CM, Dornseif BE, Bosomworth JC, Sayer ME, Rampey AH, Heiligenstein JH, Thompson VL, Murphy DJ, Masica DN: Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. Br Med J 1991; 303:685-692
12. Montgomery SA, Dunner DL, Dunbar GC: Reduction of suicidal thoughts with paroxetine in comparison with reference antidepressants and placebo. Eur Neuropsychopharmacol 1995; 5:5-13
13. Letizia C, Kapik B, Flanders WD: Suicidal risk during controlled clinical investigations of fluvoxamine. J Clin Psychiatry 1996; 57:415-421
14. Beasley CM, Potvin JH, Masica DN, Wheadon DE, Dornseif BE, Genduso LA: Fluoxetine: no association with suicidality in obsessive-compulsive disorder. J Affect Disord 1992; 24:1-10
15. Warshaw MG, Keller MB: The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders. J Clin Psychiatry 1996; 57:158-166
16. Wheadon DE, Rampey AH, Thompson VL, Potvin JH, Masica DN, Beasley CM: Lack of association between fluoxetine and suicidality in bulimia nervosa. J Clin Psychiatry 1992; 53:235-241
17. Montgomery DB, Roberts A, Green M, Bullock T, Baldwin D, Montgomery SA: Lack of efficacy of fluoxetine in recurrent brief depression and suicidal attempts. Eur Arch Psychiatry Clin Neurosci 1994; 244:211-215
18. Norden MJ: Fluoxetine in borderline personality disorder. Prog Neuropsychopharmacol Biol Psychiatry 1989; 13:885-893
19. Cornelius JR, Soloff PH, Perel JM, Ulrich RF: A preliminary trial of fluoxetine in refractory borderline patients. J Clin Psychopharmacol 1991; 11:116-120
20. Markovitz PJ, Calabrese JR, Schulz SC, Meltzer HY: Fluoxetine in the treatment of borderline and schizotypal personality disorders. Am J Psychiatry 1991; 148:1064-1067
21. Coccaro EF, Astill JL, Herbert JL, Schut AG: Fluoxetine treat ment of impulsive aggression in DSM-III-R personality disorder patients. J Clin Psychopharmacol 1990; 10:373-375
22. Kavoussi RJ, Liu J, Coccaro EF: An open trial of sertraline in personality disordered patients with impulsive aggression. J Clin Psychiatry 1994; 55:137-141
23. Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, Swartz J, Miyawaki E: Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 1995; 15:23-29
24. Buglass D, Horton J: A scale for predicting subsequent suicidal behavior. Br J Psychiatry 1974; 124:573-578
25. Soloff PH, Lis JA, Kelly T, Cornelius J, Ulrich R: Risk factors for suicidal behavior in borderline personality disorder. Am J Psychiatry 1994; 151:1316-1323
26. Raczek SW, True PK, Friend RC: Suicidal behavior and personality traits. J Personality Disorders 1989; 3:345-351
27. Isometsä ET, Henriksson MM, Heikkinen ME, Aro HM, Marttunen MJ, Kuoppasalmi KI, Lönnqvist JK: Suicide among subjects with personality disorders. Am J Psychiatry 1996; 153:667-673
28. Johnsson Fridell E, Öjehagen A, Träskman-Bendz L: A 5-year follow-up study of suicide attempts. Acta Psychiatr Scand 1996; 93:151-157
29. Kreitman N, Casey P: Repetition of parasuicide: an epidemiological study. Br J Psychiatry 1988; 153:792-800
30. Hyler SE, Skodol AE, Kellman HD, Oldham JM, Rosnick L: Validity of the Personality Diagnostic Questionnaire - Revised: comparison with two structured interviews. Am J Psychiatry 1990; 147:1043-1048
31. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4:561-571
32. Beck AT, Steer RA: Manual for the Beck Hopelessness Scale. San Antonio, Tex, Psychological Corp, 1988
33. Spielberger CD: State-Trait Anger Expression Inventory. Odessa, Fla, Psychological Assessment Resources, 1988
34. Kremer HPH, Goekoop JG, Van Kempen GMJ: Clinical use of the determination of serotonin (5-HT) in whole blood. J Clin Psychopharmacol 1990; 10:83-87
35. Rubey RN, Johnson MR, Emmanuel N, Lydiard RB: Fluoxetine in the treatment of anger: an open clinical trial. J Clin Psychiatry 1996; 57:398-401